feed,title,long_url,short_url
Benzinga,Merck's Chronic Cough Treatment Candidate Receives Second Time FDA Rejection,https://benzinga.com/general/biotech/23/12/36339707/mercks-chronic-cough-treatment-candidate-receives-second-time-fda-rejection,https://da.gd/sAkYOi
Benzinga,Why Longeveron (LGVN) Shares Are Falling Sharply,https://benzinga.com/news/23/12/36342376/why-longeveron-lgvn-shares-are-falling-sharply,https://da.gd/E0WBv
Benzinga,European Drugmaker Sanofi Ends Tusamitamab Ravtansine Lung Cancer Program After Disappointing Data,https://benzinga.com/general/biotech/23/12/36339253/european-drugmaker-sanofi%C2%AC-ends%C2%AC-tusamitamab-ravtansine-lung-cancer-program-after-disappointing-d,https://da.gd/NAgRF
